The Efficacy and Safety of Baduanjin in Patients with Coronary Heart
Disease After Percutaneous Coronary Intervention：A Systematic Review
Objective: To evaluate the effects of Baduanjin on quality of life
(QOL), psychological status and cardiac function of patients with
coronary heart disease after percutaneous coronary intervention (PCI).
Methods: PubMed, The Cochrance Library, Embase, Web of Science, China
Biology Medicine disc, CNKI, VIP and Wanfang were searched by a computer
for any randomized controlled trials of Baduanjin intervention in
patients with coronary heart disease after PCI, including relevant
conference articles and academic papers published in journals. The
retrieval time was from the database creation time to September 7, 2020.
After two evaluators independently screened the literature, extracted
relevant data and evaluated the bias risk for the included studies,
RevMan5.3 software was used for a data analysis. Results:A total of 9
articles and 846 patients were included. The meta-analysis showed that
the Baduanjin group was superior to the conventional western medicine
treatment group in physical hunctioning、role-physical 、general
health、role-emotional 、mental health、 anxiety、 anxiety、left
ventricular ejection fraction、blood pressure、stroke volume，and the
differences were statistically significant.But the Baduanjin group
was not superior to the control group in bodily pain、vitality、social
functioning,and the differences were not statistically significant.
Conclusion: Baduanjin can improve the cardiac function, regulate the
psychological state and improve the QOL among patients with coronary
heart disease after PCI.